Back to AFFLUENT MEDICALInsider 
Company
TRUFFLE CAPITAL SAS — AFFLUENT MEDICAL
Filing 2026DD1123892Published 1 Jul 2026France public disclosures
InitialEffective
Summary
TRUFFLE CAPITAL SAS
Philippe POULETTY, Directeur Général Truffle Capital
AFFLUENT MEDICAL
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyAFFLUENT MEDICAL
ISINFR0013333077
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€2,599,998.24
Reported sales
€0.00
Net buy/sell
€2,599,998.24
Other reported value
€0.00
Gross reported value
€2,599,998.24
Transactions
1
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 25 Jun 2026 | BuyAcquisition / BUY | ACQUISITION | SHARE | UNKNOWN | 773,809 | €3.36 | €2,599,998.24 | XOFF |
Buy
Execution date25 Jun 2026Acquisition / BUY
ACQUISITION · SHARE · UNKNOWN · XOFF
- Quantity
- 773,809
- Unit price
- €3.36
- Total
- €2,599,998.24
Evidence
- AMF · France2026DD1123892
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.